DK308488A - Farmaceutisk praeparat til behandling af en retrovirusinfektion - Google Patents

Farmaceutisk praeparat til behandling af en retrovirusinfektion

Info

Publication number
DK308488A
DK308488A DK308488A DK308488A DK308488A DK 308488 A DK308488 A DK 308488A DK 308488 A DK308488 A DK 308488A DK 308488 A DK308488 A DK 308488A DK 308488 A DK308488 A DK 308488A
Authority
DK
Denmark
Prior art keywords
treating
pharmaceutical preparation
retrovirus infection
retrovirus
infection
Prior art date
Application number
DK308488A
Other languages
Danish (da)
English (en)
Other versions
DK308488D0 (da
Inventor
Sai Prasad Sunkara
Terry L Bowlin
Paul S Liu
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK308488D0 publication Critical patent/DK308488D0/da
Publication of DK308488A publication Critical patent/DK308488A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK308488A 1987-06-08 1988-06-07 Farmaceutisk praeparat til behandling af en retrovirusinfektion DK308488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5896287A 1987-06-08 1987-06-08

Publications (2)

Publication Number Publication Date
DK308488D0 DK308488D0 (da) 1988-06-07
DK308488A true DK308488A (da) 1988-12-09

Family

ID=22019972

Family Applications (1)

Application Number Title Priority Date Filing Date
DK308488A DK308488A (da) 1987-06-08 1988-06-07 Farmaceutisk praeparat til behandling af en retrovirusinfektion

Country Status (7)

Country Link
EP (1) EP0295538A3 (xx)
JP (1) JP2720169B2 (xx)
KR (1) KR890000097A (xx)
AU (1) AU608853B2 (xx)
DK (1) DK308488A (xx)
PH (1) PH25896A (xx)
ZA (1) ZA883925B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
GB8827701D0 (en) * 1987-12-09 1988-12-29 Nippon Shinyaku Co Ltd Thrombolytic &c compositions
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
FR2632526B1 (fr) * 1988-06-10 1994-05-13 Pasteur Institut Composition pharmaceutique active sur les residus glucose de la glycoproteine gp 150
JPH04500959A (ja) * 1988-08-10 1992-02-20 ジ オーストラリアン ナショナル ユニバーシティー 抗炎症剤および免疫抑制剤としてのカスタノスペルミンの使用
AU618838B2 (en) * 1988-08-10 1992-01-09 Praxis Pharmaceuticals, Inc. Use of castanospermine as an anti-inflammatory and immunosuppressant agent
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
US5908867A (en) * 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
AU736668B2 (en) * 1996-10-01 2001-08-02 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
JP2001521036A (ja) * 1997-10-24 2001-11-06 グリコデザイン インコーポレイテッド スワインソニン塩の合成
JP2001525367A (ja) * 1997-12-11 2001-12-11 ザ・チャンセラー・マスターズ・アンド・スカラーズ・オブ・ザ・ユニバーシティ・オブ・オックスフォード 膜関連ウイルス複製の阻害
US6670374B1 (en) * 2002-06-11 2003-12-30 The United States Of America As Represented By The Secretary Of Agriculture Swainsonine compounds as inhibitors of toxin receptor expression
GB0501352D0 (en) * 2005-01-21 2005-03-02 Slingsby Jason H Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
CN101304762A (zh) * 2005-02-09 2008-11-12 米珍尼克斯公司 治疗或预防黄病毒科感染的组合物和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
EP0282618A1 (en) * 1987-03-18 1988-09-21 Vereniging Het Nederlands Kanker Instituut 1-Deoxynojirimycin as an anti-HIV therapeutic
KR910010020B1 (ko) * 1987-12-21 1991-12-10 몬산토 캄파니 항바이러스제

Also Published As

Publication number Publication date
PH25896A (en) 1991-12-19
EP0295538A3 (en) 1991-04-03
EP0295538A2 (en) 1988-12-21
AU1739788A (en) 1988-12-08
DK308488D0 (da) 1988-06-07
ZA883925B (en) 1989-02-22
AU608853B2 (en) 1991-04-18
JPS63310819A (ja) 1988-12-19
JP2720169B2 (ja) 1998-02-25
KR890000097A (ko) 1989-03-11

Similar Documents

Publication Publication Date Title
DK204587A (da) Fremgangsmaade til fremstilling af et opbevaringsstabilt koncentrat, til fremstilling af et desinficeringsmiddel
DK89090D0 (da) Farmaceutisk praeparat
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DK664387D0 (da) Fremgangsmaade til fremstilling af et anti-inflammatorisk farmaceutisk praeparat
DK100488A (da) Farmaceutisk plaster
DK217188D0 (da) Farmaceutisk praeparat til behandling af neurologiske sygdomme
DK308488A (da) Farmaceutisk praeparat til behandling af en retrovirusinfektion
DK705488A (da) Farmaceutisk praeparat
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK473088D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK425287D0 (da) Fremstilling af et farmaceutisk praeparat til behandling af kongestivt hjertesvigt
DK473288D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK139388D0 (da) Farmaceutisk praeparat
DK680787A (da) Farmaceutisk praeparat indeholdende en pyranoquinolinforbindelse
DK276288A (da) Farmaceutisk praeparat
DK651588A (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK265789D0 (da) Fremstilling af et farmaceutisk praeparat
DK72288A (da) Farmaceutisk praeparat til behandling af ulcerativ tyktarmssygdom
DK348687D0 (da) Fremgangsmaade til fremstilling af en terapeutisk virksom forbindelse
DK669287D0 (da) Farmaceutisk praerarat indeholdende en pyranoquinolinforbindelse
DK469487A (da) Laegemiddel til behandling af fedme
DK138888A (da) Farmaceutisk praeparat
DK473188D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
IT8721670A0 (it) Composizioni farmaceutiche a basedi ottreotide.
SE8603912D0 (sv) Farmaceutisk beredning

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment